Latest filing published 04 Feb 2014 for CRITICAL THERAPEUTICS INC, €81.3M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Chiesi Farmaceutici SpA discloses dealings in Critical Therapeutics Inc to SEC (Form 4). In total, 11 filings cover trades dated from 14 October 2009 to 3 February 2014.
Purchases make up the whole of the open-market record (7 purchases, €88.2M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants. So far in 2014, the count stands at 1 purchase and no sales.
Half of the purchases are above €16k and half below.
The newest entry dates from 4 February 2014: an open-market purchase of €81.3M, in Critical Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations